Clinical Oncology - Issue Supplementum 2/2015
6
What Can Study of Oligomerization of Proteinsin the Process of Oncogenesis Bring Us?
D. Coufalová, B. Vojtěšek, L. Hernychová
11
Analysis of Phosphoproteome Changes in MDA‑ MB‑ 468 Cancer Cell Line in Response to Expression of p63 Isoforms Using Mass Spectrometry
P. Dvořáková, M. Nekulová, J. Holčáková, B. Vojtěšek, L. Hernychová
20
‘Sugars Interfere’ or Glycomics in the Field of Cancer Biomarkers
M. Zahradníková, B. Vojtěšek, L. Hernychová
26
Nrf2 – Two Faces of Antioxidant System Regulation
M. Pastorek, P. Müller, B. Vojtěšek
32
Polo‑like Kinase 1 as a Target for Anti‑tumor Therapy
I. Procházková, B. Vojtěšek
40
PDLIM2 and Its Role in Oncogenesis – Tumor Suppressor or Oncoprote?
J. Maryáš, P. Bouchal
47
Profile of Activation of Tyrosine Kinases and MAP Kinases in Therapy of Maffucci Syndrome
K. Melichárková, J. Neradil, P. Múdrý, K. Zitterbart, R. Obermannová, J. Skotáková, R. Veselska, J. Štěrba
52
Recombinant Antibodies and Their Employment in Cancer Therapy
E. Růčková, P. Müller, B. Vojtěšek
60
Immunological Aspects in Oncology – Circulating γδ T Cells
M. Cibulka, I. Selingerová, L. Fědorová, Zdražilová Dubská L.
69
Circulating Tumor DNA in Blood and Its Utilization as a Potential Biomarker for Cancer
E. Ondroušková, R. Hrstka
75
Adenoviral Vectors in Gene Therapy
M. Pjechová, L. Hernychová, P. Tomašec, G. W. Wilkinson, B. Vojtěšek
81
Cancer in Adolescents
V. Bajčiová, Z. Onderčová, D. Kodýtková
91
Bioinformatics and Next‑ generation Sequencing
A. Krejčí, P. Müller, B. Vojtěšek
Clinical Oncology
2015 Číslo Supplementum 2
Najčítanejšie v tomto čísle
- Adenoviral Vectors in Gene Therapy
- Recombinant Antibodies and Their Employment in Cancer Therapy
- Nrf2 – Two Faces of Antioxidant System Regulation
- What Can Study of Oligomerization of Proteinsin the Process of Oncogenesis Bring Us?